Guangzhou Berui Pharmaceutical and Dental - Feasibility Study of Entering the Remote Medical Diagnosis Market
Company overview
Berui Pharmaceutical was founded in 2001 and is a pharmaceutical supply chain services company holding Good Supply Practice (GSP) certification. The company's business operations cover pharmaceutical raw material imports and exports, drug import registration, bioequivalence evaluation services, reference originator formulations, PEG and its derivatives, BIA whole-column separation columns, and other specialized modules. Over the years, Berui Pharmaceutical has built a strong professional reputation and a stable supply chain partnership network within the industry.
Research background
Driven by supportive national policies and increasing public health awareness, the Chinese dental healthcare market has experienced rapid expansion, yet still lags significantly behind international benchmarks. To extend its industrial chain and secure an early-mover advantage in the dental services sector, Berui Pharmaceutical plans to develop an O2O-based remote dental diagnosis system that directly connects dentists with patients, enabling online diagnosis and preventive care management. Prior to investment, the company needs to assess market acceptance and operational feasibility to provide strategic decision support for future operations and investment.
Research scope
In February 2017, CEIDEA Research was commissioned by Berui Pharmaceutical to conduct a market feasibility study on remote dental services. The study targeted potential consumers, covering users across different age groups, genders, and occupational backgrounds, systematically gathering insights on their level of acceptance, willingness to use, price sensitivity, service expectations, and usage scenarios for remote dental care services. The research will also evaluate the commercial viability and market potential of this business model.
Expected outcomes
The research report will comprehensively reveal actual user needs and psychological expectations regarding remote dental services, providing Berui Pharmaceutical with data-driven insights and strategic recommendations for market entry in new business segments, precise business model positioning, identification of core user segments, product design, and communication strategies. This will support the company's vertical expansion of its industrial chain and innovation in its business model.
Scan to add our research consultant